Patents Assigned to Tianjin Zhongxin Pharmaceutical Group Corp., LTD. Research Institute Branch Company
  • 13-OXIDIZED INGENOL DERIVATIVE AND USE THEREOF
    Publication number: 20210147334
    Abstract: The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 20, 2021
    Applicant: Tianjin Zhongxin Pharmaceutical Group Corp., LTD. Research Institute Branch Company
    Inventors: Xiao Wu, Qin Pan, Yanyun Li, Yu Yang, Yuzhen Guan, Xiaolei Wu, Chuanteng Sun, Yuan Wang
  • 13-OXIDIZED INGENOL DERIVATIVE AND USE THEREOF
    Publication number: 20200140369
    Abstract: The present invention relates to a derivative of 13-oxidized ingenol, use thereof in the prevention and/or treatment of a disease associated with proliferation or tumor in a subject, or a cosmetic indication, and use thereof in the prevention and/or treatment of a disease responsive to neutrophil oxidative burst, a disease responsive to a release of IL-8 by keratinocyte, or a disease responsive to induction of necrosis.
    Type: Application
    Filed: June 7, 2018
    Publication date: May 7, 2020
    Applicant: Tianjin Zhongxin Pharmaceutical Group Corp., LTD. Research Institute Branch Company
    Inventors: Xiao Wu, Qin Pan, Yanyun Li, Yu Yang, Yuzhen Guan, Xioalei Wu, Chuanteng Sun, Yuan Wang